Your browser doesn't support javascript.
loading
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial.
Lamy, Andre; Eikelboom, John; Tong, Wesley; Yuan, Fei; Bangdiwala, Shrikant I; Bosch, Jackie; Connolly, Stuart; Lonn, Eva; Dagenais, Gilles R; Branch, Kelley R H; Wang, Wei-Jhih; Bhatt, Deepak L; Probstfield, Jeff; Ertl, Georg; Störk, Stefan; Steg, P Gabriel; Aboyans, Victor; Durand-Zaleski, Isabelle; Ryden, Lars; Yusuf, Salim.
Afiliação
  • Lamy A; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Eikelboom J; CADENCE Research Group, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Tong W; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Yuan F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Bangdiwala SI; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Bosch J; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Connolly S; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Lonn E; CADENCE Research Group, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Dagenais GR; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Branch KRH; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Wang WJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Bhatt DL; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Probstfield J; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Ertl G; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Störk S; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Steg PG; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Aboyans V; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Durand-Zaleski I; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Québec, Canada.
  • Ryden L; University of Washington Medical Center, Seattle, WA, USA.
  • Yusuf S; Comparative Health Outcomes, Policy and Economics Institute, School of Pharmacy, University of Washington, USA.
Eur Heart J Qual Care Clin Outcomes ; 9(5): 502-510, 2023 08 07.
Article em En | MEDLINE | ID: mdl-36001989
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Aspirina / Doença Arterial Periférica Tipo de estudo: Health_economic_evaluation Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur Heart J Qual Care Clin Outcomes Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Aspirina / Doença Arterial Periférica Tipo de estudo: Health_economic_evaluation Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur Heart J Qual Care Clin Outcomes Ano de publicação: 2023 Tipo de documento: Article